More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 27 individual studies and over 10,000 PCR test cup runs
Expansion coincides with Co-Dx webinar for prospective mosquito abatement district customers in honor of National Mosquito Control Awareness Week
Visit has included tour of Utah headquarters and automated manufacturing facilities ahead of planned technology transfer
Longstanding distribution partner to support future deployment of Co-Dx™ PCR Pro ® and expanding menu of molecular diagnostics products across a key Latin American market
Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regions
Global health emergencies are shifting sovereign biodefense strategies toward decentralized diagnostic networks capable of deploying rapid stockpiles.
Joint development strategy has been developed to address international deployment requirements if current outbreak continues or expands globally
Recent pathogens illustrate need for improved situational awareness capabilities, such as those provided by the Co-Dx PCR point-of-care platform
Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Lease execution highlights transition from approval to development and advances localized manufacturing strategy in the Kingdom of Saudi Arabia in accordance with Vision 2030